GCGR and type 1 diabetes mellitus: The peptidyl glucagon receptor antagonist des-His1-Glu9-GCG (28, 29) only reduced fasting blood glucose levels markedly in the high dose group (4 mg/kg) in T1DM (Fig. 9, A and B).